Gainers
-
Stellar Biotechnologies Inc (NASDAQ: SBOT) shares jumped 105 percent to $2.46 after the company reported a share
exchange deal with Edesa Biotech.
-
TrovaGene, Inc. (NASDAQ: TROV) shares
climbed 65.7 percent to $6.84 on continued strength after traders on Thursday circulated word of an FDA abstract document for
the company's prostate cancer treatment; analysts at Maxim and Noble Financial reiterated bullish positions on the stock.
-
Seelos Therapeutics, Inc. (NASDAQ: SEEL) shares climbed 41.1 percent to $4.29 after surging 96.13 percent on
Thursday. Seelos Therapeutics reported an offering for 15.96 million shares via selling shareholders.
-
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) gained 37.9 percent to $2.95 after the company late Thursday announced a
new European use patent for its TNX-601 PTSD treatment candidate.
-
Selecta Biosciences, Inc. (NASDAQ: SELB) climbed 27.6 percent to $2.59 after gaining 7.41 percent on Thursday.
-
SAExploration Holdings Inc (NASDAQ: SAEX) rose 24.5 percent to $4.5850 after the company announced $60 million of
new projects in Alaska and Southeast Asia.
-
Nature's Sunshine Products, Inc. (NASDAQ: NATR) climbed 23.4 percent to $8.50 after the company reported Q4 EPS of
$(0.15) compared to $(0.19) last year, and sales of $97.37 million, compared to $88.29 million last year.
-
DXP Enterprises, Inc. (NASDAQ: DXPE)
surged 21.3 percent to $38.44 after the company reported Q4 EPS of $0.60, compared to $0.29 last year, and sales of $311
million, compared to $265.627 million last year.
-
AutoWeb, Inc. (NASDAQ: AUTO) gained 21
percent to $4.10 following Q4 results. B. Riley FBR upgraded AutoWeb from Neutral to Buy and raised the price target from $3.20
to $5.
-
Big Lots, Inc. (NYSE: BIG) shares rose
16.5 percent to $37.09 after the company reported higher-than-expected Q4 EPS results and announced a $50 million buyback.
-
Upland Software, Inc. (NASDAQ: UPLD)
gained 15 percent to $38.84 after the company reported better-than-expected results for its fourth quarter.
-
Calithera Biosciences, Inc. (NASDAQ: CALA) shares rose 14.3 percent to $5.85 following Q4 results.
-
Celldex Therapeutics, Inc. (NASDAQ: CLDX) climbed 13.5 percent to $5.22 following strong Q4 results.
-
Myomo Inc (NYSE: MYO) gained 10.8 percent
to $1.3299 after the company reported Q4 EPS and sales results above analyst estimates.
-
Red Lion Hotels Corporation (NYSE: RLH)
shares climbed 10.4 percent to $8.20 after reporting Q4 results.
-
Neonode Inc. (NASDAQ: NEON) shares
rose 9.5 percent to $2.65.
-
Phunware Inc. (NASDAQ: PHUN) shares
gained 9.2 percent to $39.30.
-
IDT Corporation (NYSE: IDT) surged 9.1
percent to $6.23 following Q2 results.
-
Energy Recovery, Inc. (NASDAQ: ERII)
gained 9.1 percent to $8.55 after the company reported higher-than-expected Q4 EPS and sales results.
-
Big Lots, Inc. (NYSE: BIG) shares rose
8.3 percent to $34.47 after reporting better-than-expected earnings for its fourth quarter.
-
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) surged 7.2 percent to $3.57.
-
Vail Resorts, Inc. (NYSE: MTN) gained 6.8
percent to $216.10 after the company reported higher-than-expected Q2 EPS and sales results.
-
Costco Wholesale Corporation (NASDAQ: COST) rose 4.7 percent to $226.91 after the company reported
stronger-than-expected earnings for its fiscal second quarter.
-
Horizon Pharma plc (NASDAQ: HZNP) rose
4.6 percent to $27.00. Morgan Stanley upgraded Horizon Pharma from Equal-Weight to Overweight.
Check out these big penny stock gainers and
losers
Losers
-
CHF Solutions, Inc. (NASDAQ: CHFS)
shares dropped 43.8 percent to $4.44 after the company filed for a $6.21 million offering.
-
Bio-Path Holdings, Inc. (NASDAQ: BPTH)
dipped 34.3 percent to $25.55 in a potential sell off after the stock rose nearly 600 percent over the past few trading
sessions.
-
Altimmune, Inc. (NASDAQ: ALT) shares
fell 32.8 percent to $3.05 after surging 50.33 percent on Thursday. Altimmune reported a $14 million registered direct
offering.
-
NV5 Global, Inc. (NASDAQ: NVEE) shares
dropped 28.7 percent to $54.90 after the company reported lower-than-expected Q4 EPS and sales.
-
Eventbrite Inc (NYSE: EB) shares declined
25.3 percent to $24.23 after the company reported a wider-than-expected Q4 loss and issued weak earnings forecast.
-
China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) fell 24.2 percent to $3.3734.
-
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) dipped 21.2 percent to $10.81 after the company reported topline results
from its PROLONG trial did not demonstrate any statistically significant difference between the treatment and placebo arms for
co-primary endpoints.
-
T2 Biosystems, Inc. (NASDAQ: TTOO)
declined 20.1 percent to $2.5099 following Q4 results.
-
Orion Engineered Carbons, S.A. (NYSE: OEC) shares fell 18.6 percent to $21.45 following Q4 results.
-
National Beverage Corp. (NASDAQ: FIZZ)
dropped 18 percent to $56.00 after the company reported lower-than-expected Q3 EPS and sales results; Guggenheim analysts
subsequently downgraded the company's stock from 'Neutral' to 'Sell'.
-
Great Elm Capital Group, Inc. (NASDAQ: GEC) shares declined 17.9 percent to $3.9000.
-
The Alkaline Water Company Inc. (NASDAQ: WTER) shares fell 16.4 percent to $2.6740 after the company priced a 4 million
share common stock offering at $2.50 per share.
-
Bioblast Pharma Ltd. (NASDAQ: ORPN)
shares dropped 15.5 percent to $13.02.
-
American Renal Associates Holdings, Inc. (NYSE: ARA) dipped 14.6 percent to $10.68 after the company announced a delay in its
fourth quarter and full year 2018 earnings release.
-
El Pollo Loco Holdings, Inc. (NASDAQ: LOCO) shares dropped 14.1 percent to $12.93 after the company posted downbeat
Q4 sales and issued weak FY19 earnings forecast.
-
Qualstar Corporation (NASDAQ: QBAK)
shares fell 13.1 percent to $5.48 following Q4 results.
-
JMU Limited (NASDAQ: JMU) tumbled 12.7
percent to $2.40.
-
HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares fell 12.3 percent to $2.2885 after the company reported
lower-than-expected Q4 sales and issued weak Q1 and FY19 guidance.
-
HCI Group, Inc. (NYSE: HCI) dipped 11.8
percent to $38.27 after reporting Q4 results.
-
Cleveland BioLabs, Inc. (NASDAQ: CBLI)
shares declined 11.7 percent to $1.73.
-
Translate Bio, Inc. (NASDAQ: TBIO)
shares fell 11.2 percent to $8.73.
-
Liquidia Technologies, Inc. (NASDAQ: LQDA) dipped 11.1 percent to $16.00.
-
California Resources Corporation (NYSE: CRC) shares dropped 9.9 percent to $19.21.
-
American Outdoor Brands Corp (NASDAQ: AOBC) fell 9.6 percent to $10.28 following the release of the company's Q3
earnings.
-
Korn Ferry (NYSE: KFY) shares fell 6.6
percent to $43.38 after reporting Q3 results.
-
Okta Inc (NASDAQ: OKTA) fell 4.4
percent to $77.68 after the company issued weak earnings guidance.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.